Advertisements



Cytokinetics announces data from Phase 2 clinical study of Reldesemtiv in SMA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 17th, 2018

Cytokinetics announces data from Phase 2 clinical study of Reldesemtiv in SMA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 17th, 2018

Synlogic announces publication of clinical data from Phase 1 study of SYNB1020

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 16th, 2019

Proteostasis Plunges on Weak Data From Cystic Fibrosis Study

Proteostasis (PTI) announces data from a phase I study evaluating its triplet combination in cystic fibrosis. Although data were promising, it was weaker than rival Vertex's triplet combinations. Want the.....»»

Category: worldSource: nyt8 hr. 27 min. ago

IMV Inc. announces preliminary data from Phase 2 cohort of DECIDE study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall11 hr. 57 min. ago

Altimmune announces additional data from phase 2 NasoVAX study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 19th, 2019

BeyondSpring announces new clinical data from Study 106 program for Plinabulin

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 26th, 2019

Recro Pharma publishes clinical data from Phase III study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 25th, 2019

BrainStorm announces first U.S.clinical site for Phase 2 MS study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 22nd, 2019

Xencor announces partial clinical hold on Phase 1 study of XmAb14045

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 20th, 2019

Motus GI Holdings announces publication of Pure-Vu system clinical study data

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 19th, 2019

Deciphera announces "positive" preliminary data from Phase 1 study with DCC-3014

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 2nd, 2019

Neurotrope announces publication of data from Phase 2 study of Bryostatin-1

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 17th, 2018

Gamida Cell publishes data from Phase 1/2 clinical study of NiCord

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 4th, 2018

Kite Pharma announces updated Zuma-3 data from KTE-X19 Phase 1/2 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 3rd, 2018

MacroGenics announced clinical data from ongoing Phase 1 study of flotetuzumab

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 3rd, 2018

Apellis announces updated new data from APL-2 Phase 2 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 3rd, 2018

Catalyst announces positive data from Phase 2/3 study of Marzeptacog Alfa

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 2nd, 2018

Akari Announces Third Quarter 2018 Financial Results and Business Highlights

Four ongoing clinical trial programs Two clinical programs expected to report initial data in first quarter 2019 Long-term clinical study continues to yield encouraging safety data NEW YORK and LONDON, Nov. 15, 2018 (GLOBE NEWSWIRE) --.....»»

Category: earningsSource: benzingaNov 15th, 2018

Enanta announces EDP-938 Phase 1 results, initiates Phase 2a clinical study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 23rd, 2018

Why Clovis Oncology Faces Some Difficulty With Its Midstage Cancer Study

Clovis Oncology shares dropped on Friday after the company announced initial data from its Phase 2 clinical trial of Rubraca at the ESMO 2018 Congress......»»

Category: blogSource: 247wallstOct 19th, 2018